Plasma and Peritoneal Fluid Annexin A2 Levels in Patients with Endometriosis.

annexin A2 endometriosis infertility

Journal

Journal of inflammation research
ISSN: 1178-7031
Titre abrégé: J Inflamm Res
Pays: New Zealand
ID NLM: 101512684

Informations de publication

Date de publication:
2023
Historique:
received: 15 05 2023
accepted: 06 09 2023
medline: 13 12 2023
pubmed: 13 12 2023
entrez: 13 12 2023
Statut: epublish

Résumé

Endometriosis is an inflammatory-related reproductive age disease characterized by the presence of endometrial cells outside the uterine cavity. Current laboratory practice does not provide specific markers for detecting and assessing the advancement of endometriosis in either plasma or peritoneal fluid. The severity of disease is assessed in stages from I to IV based on the results of laparoscopic inspection. The protein annexin A2 (ANXA2) has been reported to be associated with inflammatory processes. The study aimed to investigate and compare ANXA2 protein concentration using the ELISA method in plasma and peritoneal fluid in a group of women with endometriosis compared to controls. Biological material was collected during a multicenter, cross-sectional study, which was conducted at eight departments during elective laparoscopy from 53 women with and 40 women without endometriosis. Patients were divided by endometriosis stage and infertility status, and then compared with subgroups. Analysis included the Chi-square test for categorical variables, Mann-Whitney Women with endometriosis had significantly elevated plasma ANXA2 levels compared to women without endometriosis (mean concentrations 28.69 vs 19.61 ng/L, p=0.01). Differences in peritoneal fluid ANXA2 levels were statistically insignificant (mean concentrations of 23.7 vs 22.97 ng/L, p=0.06). Plasma concentrations in patients with stage III and IV endometriosis were significantly higher compared to controls (mean concentrations of 24.19 vs 19.71 ng/L, p=0.03). No such differences were observed in plasma when comparing stages I-II vs III-IV, and stages I-II vs controls (mean concentrations of 33.82 vs 24.19 ng/L, p=0.72 and 33.82 vs 19.71 ng/L, p=0.12, respectively). Comparison of samples from patients with or without infertility, primary or secondary infertility, endometriosis with or without infertility, and non-endometriosis with or without infertility showed no significant differences in the plasma nor in the peritoneal fluid concentrations. ANXA2 is possibly involved in the pathogenesis of endometriosis, especially in advanced stages. Due to the limited group of tested samples, further studies are needed to confirm its role.

Identifiants

pubmed: 38088940
doi: 10.2147/JIR.S421389
pii: 421389
pmc: PMC10713386
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5959-5969

Informations de copyright

© 2023 Zygarowicz et al.

Déclaration de conflit d'intérêts

Michal Zygarowicz, Dr Joanna Kacperczyk-Bartnik and Professor Piotr Laudanski report grant from the Medical University of Warsaw no. 1W51/1/M/MB/N/21 used for this study. Michal Zygarowicz also reports non-financial support from Medical University of Białystok. Professor Piotr Laudanski reports grant from the Polish Ministry of Health no. 6/6/4/1/NPZ/2017/1210/13522 and grant from the European Union’s Horizon 2020 Research and Innovation Program under the Marie Skłodowska-Curie grant no. 101008193 TRENDO during the conduction of the study. This study was conducted with the use of equipment purchased by Medical University of Białystok as part of the RPOWP 2007-2013 funding, Priority I, Axis 1.1, contract No. UDA- RPPD.01.01.00-20-001/15-00 dated 26.06.2015. The authors report no other conflicts of interest in this work.

Auteurs

Michal Zygarowicz (M)

Students' Scientific Group Affiliated to the Department of Obstetrics, Gynecology and Gynecological Oncology, Medical University of Warsaw, Warsaw, Poland.

Joanna Kacperczyk-Bartnik (J)

II Department of Obstetrics and Gynaecology, Medical University of Warsaw, Warsaw, Poland.
Club 35. Polish Society of Gynecologists and Obstetricians, Wrocław, Poland.

Janusz Sierdzinski (J)

Department of Medical Informatics and Telemedicine, Medical University of Warsaw, Warsaw, Poland.

Cezary Wojtyla (C)

OVIklinika Infertility Center, Warsaw, Poland.
Women's Health Research Institute, Calisia University, Kalisz, Poland.

Piotr Pierzynski (P)

OVIklinika Infertility Center, Warsaw, Poland.
Women's Health Research Institute, Calisia University, Kalisz, Poland.

Grzegorz Manka (G)

Angelius Provita Hospital, Katowice, Poland.

Mariusz Kiecka (M)

Angelius Provita Hospital, Katowice, Poland.

Robert Z Spaczynski (RZ)

Center for Gynecology, Obstetrics and Infertility Treatment Pastelova, Poznan, Poland.

Piotr Piekarski (P)

Division of Infertility and Reproductive Endocrinology, Department of Gynecology, Obstetrics and Gynecological Oncology, Poznan University of Medical Sciences, Poznan, Poland.

Beata Banaszewska (B)

Chair and Department of Laboratory Diagnostics, Poznan University of Medical Sciences, Poznan, Poland.

Artur Jakimiuk (A)

Department of Obstetrics and Gynecology, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.
Center of Reproductive Health, Institute of Mother and Child in Warsaw, Warsaw, Poland.

Tadeusz Issat (T)

Department of Obstetrics and Gynecology, Institute of Mother and Child in Warsaw, Warsaw, Poland.

Wojciech Rokita (W)

Collegium Medicum Jan Kochanowski University in Kielce, Kielce, Poland.
Clinic of Obstetrics and Gynecology, Provincial Combined Hospital in Kielce, Kielce, Poland.

Jakub Mlodawski (J)

Collegium Medicum Jan Kochanowski University in Kielce, Kielce, Poland.
Clinic of Obstetrics and Gynecology, Provincial Combined Hospital in Kielce, Kielce, Poland.

Maria Szubert (M)

Club 35. Polish Society of Gynecologists and Obstetricians, Wrocław, Poland.
Department of Gynecology and Obstetrics Medical University of Lodz, Lodz, Poland.
Department of Surgical Gynecology and Oncology, Medical University of Lodz, Lodz, Poland.

Piotr Sieroszewski (P)

Department of Gynecology and Obstetrics Medical University of Lodz, Lodz, Poland.
Department of Fetal Medicine and Gynecology, Medical University of Lodz, Lodz, Poland.

Grzegorz Raba (G)

Clinic of Obstetrics and Gynecology, Provincial Hospital, Przemysl, Poland.
Department of Obstetrics and Gynecology, University of Rzeszow, Rzeszow, Poland.

Kamil Szczupak (K)

Clinic of Obstetrics and Gynecology, Provincial Hospital, Przemysl, Poland.
Department of Obstetrics and Gynecology, University of Rzeszow, Rzeszow, Poland.

Tomasz Kluz (T)

Department of Gynecology, Gynecology Oncology and Obstetrics, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.

Marek Kluza (M)

Department of Gynecology, Gynecology Oncology and Obstetrics, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.

Michal Lipa (M)

Club 35. Polish Society of Gynecologists and Obstetricians, Wrocław, Poland.
Department of Obstetrics and Gynaecology, Warsaw Southern Hospital, Warsaw, Poland.

Damian Warzecha (D)

OVIklinika Infertility Center, Warsaw, Poland.
Department of Obstetrics and Gynaecology, Warsaw Southern Hospital, Warsaw, Poland.

Miroslaw Wielgos (M)

Premium Medical, Warsaw, Poland.
Faculty of Medicine, Lazarski University, Warsaw, Poland.

Ewa Koc-Zorawska (E)

II Department of Nephrology, Hypertension and Internal Medicine with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland.
The Academy of Applied Medical and Social Sciences, Elbląg, Poland.

Marcin Zorawski (M)

The Academy of Applied Medical and Social Sciences, Elbląg, Poland.
Department of Cardiology, Lipidology and Internal Medicine with Cardiac Intensive Care Unit, Medical University of Bialystok, Bialystok, Poland.

Piotr Laudanski (P)

OVIklinika Infertility Center, Warsaw, Poland.
Women's Health Research Institute, Calisia University, Kalisz, Poland.
Department of Obstetrics, Gynecology and Gynecological Oncology, Medical University of Warsaw, Warsaw, Poland.

Classifications MeSH